Display options
Share it on

J Biomed Biotechnol. 2005;2005(4):353-63. doi: 10.1155/JBB.2005.353.

Coherent expression chromosome cluster analysis reveals differential regulatory functions of amino-terminal and distal parathyroid hormone-related protein domains in prostate carcinoma.

Journal of biomedicine & biotechnology

I Tsigelny, D W Burton, Y Sharikov, R H Hastings, L J Deftos

Affiliations

  1. Department of Chemistry and Biochemistry, University of California, San Diego, CA 92093-0654, USA. [email protected]

PMID: 16489268 PMCID: PMC1361488 DOI: 10.1155/JBB.2005.353

Abstract

Parathyroid hormone-related protein (PTHrP) has a number of cancer-related actions. While best known for causing hypercalcemia of malignancy, it also has effects on cancer cell growth, apoptosis, and angiogenesis. Studying the actions of PTHrP in human cancer is complicated because there are three isoforms and many derived peptides. Several peptides are biologically active at known or presumed cell surface receptors; in addition, the PTHrP-derived molecules can exert effects at the cell nucleus. To address this complexity, we studied gene expression in a DU 145 prostate cancer cell line that was stably transfected with control vector, PTHrP 1-173 and PTHrP 33-173. With this model, regulatory effects of the amino-terminal portion of PTHrP would result only from transduction with the full-length molecule, while effects pertaining to distal sequences would be evident with either construct. Analysis of the expression profiles by microarrays demonstrated nonoverlapping groups of differentially expressed genes. Amino-terminal PTHrP affected groups of genes involved in apoptosis, prostaglandin and sex steroid metabolism, cell-matrix interactions, and cell differentiation, while PTHrP 33-173 caused substantial increases in MHC class I antigen expression. This work demonstrates the distinct biological actions of the amino-terminus compared to distal mid-molecule or carboxy-terminal sequences of PTHrP in prostate carcinoma cells and provides targets for further study of the malignant process.

References

  1. J Natl Cancer Inst. 1994 Aug 3;86(15):1145-51 - PubMed
  2. J Biochem. 1998 Nov;124(5):940-6 - PubMed
  3. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2732-6 - PubMed
  4. Mol Endocrinol. 2000 Feb;14(2):241-54 - PubMed
  5. Int J Cancer. 1999 Jan 18;80(2):257-64 - PubMed
  6. Cell Growth Differ. 2000 Jan;11(1):49-61 - PubMed
  7. J Immunol. 2000 Dec 15;165(12):7017-24 - PubMed
  8. Mol Cell Biol. 1995 Aug;15(8):4064-75 - PubMed
  9. Cancer. 1996 Oct 1;78(7):1384-7 - PubMed
  10. J Biol Chem. 2002 Aug 2;277(31):28109-17 - PubMed
  11. Cancer Res. 2005 Feb 15;65(4):1376-83 - PubMed
  12. Am J Physiol Cell Physiol. 2003 Dec;285(6):C1429-36 - PubMed
  13. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):855-9 - PubMed
  14. Genomics. 2004 Nov;84(5):867-75 - PubMed
  15. Endocrinology. 1996 May;137(5):1608-17 - PubMed
  16. Exp Physiol. 1990 Jul;75(4):605-8 - PubMed
  17. Endocrinology. 2002 Feb;143(2):596-606 - PubMed
  18. Regul Pept. 2002 May 15;105(2):109-20 - PubMed
  19. J Cell Biochem. 1994 Feb;54(2):145-53 - PubMed
  20. Int J Cancer. 1978 Mar 15;21(3):274-81 - PubMed
  21. Chem Biol Interact. 2003 Feb 1;143-144:401-9 - PubMed
  22. Cancer Cell Int. 2003 Oct 14;3(1):17 - PubMed
  23. Mol Carcinog. 1997 Sep;20(1):33-47 - PubMed
  24. Nat Med. 2002 Sep;8(9):995-1003 - PubMed
  25. Curr Opin Cell Biol. 2004 Jun;16(3):223-9 - PubMed
  26. J Bone Miner Res. 2001 Dec;16(12):2173-81 - PubMed
  27. Nat Genet. 2000 Oct;26(2):183-6 - PubMed
  28. Microbes Infect. 1999 Sep;1(11):887-92 - PubMed
  29. Cancer Res. 2003 Sep 1;63(17):5203-8 - PubMed
  30. J Biol Chem. 2002 May 31;277(22):19374-81 - PubMed
  31. Science. 2001 Sep 21;293(5538):2269-71 - PubMed
  32. Cancer Res. 1999 Dec 1;59(23):6015-22 - PubMed
  33. Cancer Detect Prev. 1994;18(6):443-5 - PubMed
  34. Cancer Res. 2002 May 1;62(9):2721-7 - PubMed
  35. Regul Pept. 2001 Jun 15;99(2-3):169-74 - PubMed
  36. Biochem J. 2000 Oct 1;351(Pt 1):67-77 - PubMed
  37. FASEB J. 2003 Sep;17(12):1694-6 - PubMed
  38. Endocr Rev. 1994 Feb;15(1):40-60 - PubMed
  39. Urology. 1995 Nov;46(5):681-6; discussion 686-7 - PubMed
  40. Science. 2004 Apr 23;304(5670):525-7 - PubMed
  41. Nat Genet. 2000 May;25(1):25-9 - PubMed
  42. Endocrinology. 1995 Dec;136(12):5416-22 - PubMed
  43. Am J Physiol Lung Cell Mol Physiol. 2003 Dec;285(6):L1312-22 - PubMed
  44. Nature. 2001 Jan 18;409(6818):363-6 - PubMed
  45. Am J Respir Cell Mol Biol. 2003 Dec;29(6):733-42 - PubMed
  46. Annu Rev Immunol. 2002;20:463-93 - PubMed
  47. Cancer Metastasis Rev. 2001;20(3-4):195-206 - PubMed
  48. Mol Cell. 2003 Jan;11(1):261-6 - PubMed
  49. Prostate. 2002 May 1;51(2):108-16 - PubMed
  50. Endocrinology. 2001 Sep;142(9):4096-105 - PubMed

Publication Types

Grant support